Hepatitis C Cure in Nepal

Hepatitis C testing in Nepal is highly accurate. Anti-HCV antibody test has 95-98% sensitivity after window period (4-10 weeks). HCV RNA (PCR) has 99%+ specificity and detects active infection. We use internationally certified equipment following WHO guidelines. Results available within 24-48 hours.

Anti-HCV test costs Rs. 1500-2000 at STD Nepal. HCV RNA (PCR) test Rs. 8000-15000. Genotype testing Rs. 5000-8000. Viral load quantitation Rs. 6000-10000. Consultation fee is Rs. 450. Comprehensive liver panel available. All tests include professional counseling.

Yes, Hepatitis C is now curable! Direct-Acting Antivirals (DAAs) like Sofosbuvir/Velpatasvir achieve 95-99% cure rate. Treatment duration is 8-12 weeks. Cure defined as SVR12 (sustained virologic response 12 weeks post-treatment). Early treatment prevents liver cirrhosis and cancer.

Anti-HCV antibodies appear 4-10 weeks after infection. For reliable results, test at least 8-12 weeks after exposure. HCV RNA (PCR) can detect infection as early as 1-2 weeks but is expensive. If initial test negative but symptoms present, retest 3 months later.

Many people with Hepatitis C have NO symptoms initially (80%). When present: fatigue, abdominal pain, dark urine, pale stools, jaundice, nausea. Symptoms appear 6-8 weeks after infection. Most people remain asymptomatic for 10-20 years despite chronic infection. Testing is essential.

Yes, 100% confidential. STD Nepal maintains strict privacy protocols. Results delivered privately. No information shared without consent. Coded identification protects identity. All medical records are secure. We understand the social stigma and maintain absolute confidentiality.

Hepatitis C spreads through blood-to-blood contact. Common routes: sharing injection needles, blood transfusions (pre-1992 in developed countries), occupational needlestick injuries in healthcare workers. Rarely transmitted via unprotected sex or mother-to-baby. Not spread through saliva, casual contact, or sharing utensils.

Modern DAA treatment achieves SVR (sustained virologic response) rates of 95-99%. SVR12 (negative HCV RNA 12 weeks after treatment completion) indicates cure. Previous genotype barriers are overcome. Treatment accessible and affordable in Nepal through specialized clinics like STD Nepal.

Chronic Hepatitis C can progress to: liver cirrhosis (20-30% by 30 years), hepatocellular carcinoma, liver failure, portal hypertension. Early treatment prevents 99% of complications. Liver fibrosis stage determines urgency of treatment. Regular monitoring essential for diagnosed patients.

No Hepatitis C vaccine currently exists. Prevention relies on avoiding blood-to-blood contact, sterile needle use, and safe blood transfusions. If exposed, there is no post-exposure prophylaxis. Early detection through testing and prompt treatment (DAA therapy) is the best strategy.